🎁 Black Friday: up to 50% off of annual plans
ABVC BioPharma, Inc. (ABVC)
NASDAQ: ABVC · Real-Time Price · USD
0.8663
-0.0137 (-1.56%)
At close: Nov 20, 2026, 4:00 PM EST
0.9000
+0.0337 (3.89%)
After-hours: Nov 20, 2026, 4:10 PM EST

ABVC BioPharma Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
0.010.680.250.060.095.83
Short-Term Investments
0.060.060.060.080.080.11
Cash & Short-Term Investments
0.070.750.310.140.165.94
Cash Growth
-74.17%138.20%124.51%-13.41%-97.29%38.93%
Accounts Receivable
---0.010.860.43
Receivables
0.960.761.160.761.370.43
Inventory
-----0.03
Prepaid Expenses
0.370.350.10.10.150.53
Restricted Cash
-0.650.620.661.310.74
Total Current Assets
1.42.52.181.662.997.65
Property, Plant & Equipment
14.4814.751.151.381.742
Long-Term Investments
2.481.882.262.530.840.93
Long-Term Deferred Tax Assets
----0.120.98
Other Long-Term Assets
1.921.931.952.223.151.59
Total Assets
20.321.067.547.789.5813.7

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accrued Expenses
3.133.22.953.122.441.3
Short-Term Debt
0.720.761.460.921.911.87
Current Portion of Long-Term Debt
0.80.81.091.040.34-
Current Portion of Leases
0.340.320.40.40.370.35
Current Income Taxes Payable
-0.01-0.11--
Current Unearned Revenue
0.010.010.080.080.010.01
Other Current Liabilities
2.191.070.570.430.470.17
Total Current Liabilities
7.196.166.566.15.543.69
Long-Term Leases
1.341.60.240.410.791.12
Other Long-Term Liabilities
0.02-0.020.020.010.01
Total Liabilities
8.557.766.826.536.344.83

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.030.030.010.0100.03
Additional Paid-In Capital
98.5796.0178.673.9867.9458.11
Retained Earnings
-77.25-76.86-68.95-64.05-54.9-38.48
Treasury Stock
-8.91-8.91-8.91-8.9-9.1-9.1
Comprehensive Income & Other
0.620.850.480.52-0.84-1.72
Total Common Equity
13.0511.111.231.553.18.84
Minority Interest
-1.312.19-0.5-0.30.140.03
Shareholders' Equity
11.7413.30.721.253.248.87
Total Liabilities & Equity
20.321.067.547.789.5813.7

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
3.23.473.22.773.413.34
Net Cash (Debt)
-3.13-2.73-2.88-2.63-3.252.6
Net Cash Growth
------
Net Cash Per Share
-0.12-0.14-0.25-0.61-1.031.04
Filing Date Shares Outstanding
26.2524.7115.0510.533.283
Total Common Shares Outstanding
26.1124.3213.147.913.262.87
Working Capital
-5.79-3.66-4.38-4.45-2.563.96
Book Value Per Share
0.500.460.090.200.953.09
Tangible Book Value
13.0511.111.231.553.18.84
Tangible Book Value Per Share
0.500.460.090.200.953.09
Land
12.6812.690.340.360.360.4
Buildings
2.222.222.222.232.232.24
Machinery
1.321.311.291.311.291.21
SEC Filings: 10-K · 10-Q